Hexokinase 2 Is a Pivot for Lovastatin-induced Glycolysis-to-Autophagy Reprogramming in Triple-Negative Breast Cancer Cells.

Autophagy Glycolysis Lovastatin Metabolomics Triple-negative breast cancer

Journal

Journal of Cancer
ISSN: 1837-9664
Titre abrégé: J Cancer
Pays: Australia
ID NLM: 101535920

Informations de publication

Date de publication:
2022
Historique:
received: 30 01 2022
accepted: 03 07 2022
entrez: 3 10 2022
pubmed: 4 10 2022
medline: 4 10 2022
Statut: epublish

Résumé

Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer with limited therapeutic options available. We have recently demonstrated that lovastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor, suppresses TNBC cell proliferation and stemness properties

Identifiants

pubmed: 36186902
doi: 10.7150/jca.71592
pii: jcav13p3368
pmc: PMC9516013
doi:

Types de publication

Journal Article

Langues

eng

Pagination

3368-3377

Informations de copyright

© The author(s).

Déclaration de conflit d'intérêts

Competing Interests: The authors have declared that no competing interest exists.

Références

J Cancer. 2016 Jan 01;7(2):192-9
pubmed: 26819643
Cancer. 2007 May 1;109(9):1721-8
pubmed: 17387718
Front Oncol. 2021 Jun 04;11:656687
pubmed: 34150623
ACS Appl Mater Interfaces. 2018 Feb 28;10(8):7022-7030
pubmed: 29405062
Nucleic Acids Res. 2019 Jul 2;47(W1):W556-W560
pubmed: 31114875
Neoplasia. 2017 Aug;19(8):649-658
pubmed: 28732212
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
Clin Cancer Res. 2003 Jan;9(1):10-9
pubmed: 12538446
Biochim Biophys Acta Bioenerg. 2017 Aug;1858(8):665-673
pubmed: 28283400
Ultrastruct Pathol. 2018 Sep-Oct;42(5):409-415
pubmed: 30300062
Cell Death Differ. 2015 Feb;22(2):364
pubmed: 25578149
Anticancer Drugs. 2014 Aug;25(7):735-44
pubmed: 24637578
J Biol Chem. 2013 Aug 16;288(33):23798-806
pubmed: 23836898
Cancer Manag Res. 2020 Dec 23;12:13259-13271
pubmed: 33380833
Mol Cell. 2014 Feb 20;53(4):521-33
pubmed: 24462113
Autophagy. 2015;11(6):963-4
pubmed: 26075878
Cancer Discov. 2019 Feb;9(2):176-198
pubmed: 30679171
J Cancer. 2020 Mar 31;11(13):3713-3716
pubmed: 32328175
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Front Chem. 2018 Apr 06;6:108
pubmed: 29682501
Planta Med. 2020 Feb;86(3):212-219
pubmed: 31853912
Clin Transl Sci. 2020 May;13(3):563-572
pubmed: 31917509
Prostate. 2010 Jun 15;70(9):971-81
pubmed: 20135644
ACS Appl Mater Interfaces. 2021 Aug 4;13(30):35281-35293
pubmed: 34309373
Neoplasia. 2012 Apr;14(4):311-23
pubmed: 22577346
Arterioscler Thromb Vasc Biol. 2001 Nov;21(11):1712-9
pubmed: 11701455
Oncol Lett. 2017 Dec;14(6):7993-7999
pubmed: 29344241
Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):5425-30
pubmed: 25870263
Mol Cell Biol. 2008 Feb;28(3):1007-17
pubmed: 18039843

Auteurs

Lian Xue (L)

Key Laboratory of Translational Cancer Stem Cell Research, Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan 410013, China.

Mi Wu (M)

Key Laboratory of Translational Cancer Stem Cell Research, Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan 410013, China.

Ying Li (Y)

Key Laboratory of Translational Cancer Stem Cell Research, Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan 410013, China.

Sisi Chen (S)

Key Laboratory of Translational Cancer Stem Cell Research, Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan 410013, China.

Muyao Wu (M)

Key Laboratory of Translational Cancer Stem Cell Research, Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan 410013, China.

Jianyu Zhu (J)

Department of Biochemistry and Molecular Biology, Jishou University, Jishou, Hunan, China.

Siyu Ding (S)

Key Laboratory of Translational Cancer Stem Cell Research, Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan 410013, China.

Qiuting Zhang (Q)

Key Laboratory of Translational Cancer Stem Cell Research, Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan 410013, China.

Chanjuan Zheng (C)

Key Laboratory of Translational Cancer Stem Cell Research, Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan 410013, China.

Guangchun He (G)

Key Laboratory of Translational Cancer Stem Cell Research, Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan 410013, China.

Shujun Fu (S)

Key Laboratory of Translational Cancer Stem Cell Research, Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan 410013, China.

Guifei Li (G)

Key Laboratory of Translational Cancer Stem Cell Research, Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan 410013, China.
Department of Nursing, Hunan Normal University School of Medicine, Changsha, Hunan 410013, China.

Xiyun Deng (X)

Key Laboratory of Translational Cancer Stem Cell Research, Department of Pathophysiology, Hunan Normal University School of Medicine, Changsha, Hunan 410013, China.

Classifications MeSH